SEO URLwww.firestrike.ai/deals/servier-insilico-medicine-acquisition-2026
acquisitionAnnounced · Jan 5, 2026BiotechnologySource · CredibleArticle · Factual
Insilico Medicine acquires Servier
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$888M
Target
Servier
Acquirer
Insilico Medicine
Financial Stake
Status
Announced
Insilico Medicine agreed to acquire Servier. Reported deal value: $888M. Status: Announced. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-05. Figures and status may change as filings and press coverage update.
Biotechnology 5 January 2026 China-based Insilico Medicine , an AI-driven drug discovery firm, announced a multi-year research and development collaboration with privately-held French pharma major Servier valued at up to $ 888 million
Deal timeline
Announced
Jan 5, 2026 · thepharmaletter.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $888M. Figures and status may change as sources update.
Sources: thepharmaletter.com · Primary article · FireStrike proprietary index